doi: 10.1136/bmj.f839
The molecule was first isolated by Pickart in 1973 as the active component of human albumin fraction responsible for inducing older liver tissue to synthesize proteins characteristic of younger tissue an observation that led to subsequent decades of research into GHK-Cus effects on wound healing, skin regeneration, gene expression, and cellular senescence
This compound exhibits various physiological activities in vitro, including antibacterial, anti-inflammatory, antioxidative, and antitumor effects [34,35,36,37,38]
As many of these compounds aren't new discoveries, they were researched decades ago and shelved, sometimes for commercial reasons, sometimes simply because society wasn't ready for at-home injecting